Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Balance Sheet
SHPH balance sheet, 2025
December 31, 2025 · U.S. dollars$10.5M assets = $8.2M liabilities + $2.3M equity
Both columns are drawn to the same scale: what SHPH owns equals what it owes plus shareholders’ equity. Hover a block for its value.
SHPH financial health
Descriptive bands, not a rating. Fiscal 2025.
SHPH balance sheet trends, 2017–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $121,2982017 | $10.5M2025 | +89.1%/yr | |
| Total liabilities | $405,6462017 | $8.2M2025 | +53.7%/yr | |
| Shareholders’ equity | −$284,3482017 | $2.3M2025 | — | |
| Cash & short-term investments | $50,7092017 | $334,0052025 | +30.9%/yr | |
| Total debt | $314,3772017 | $232,1472025 | −4.2%/yr | |
| Net cash (debt) | −$263,6682017 | $101,8582025 | +$365,526 | |
| Working capital | −$303,1862017 | −$7.5M2025 | −$7.2M | |
| Book value per share | −$0.212017 | $0.692024 | — | |
| Current ratio | 0.252017 | 0.062025 | −0.19 | |
| Debt / equity | 14.572018 | 0.102025 | −14.47 | |
| Shares outstanding | 1.4M2017 | 1.0M2024 | −4.5%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
SHPH assets
SHPH liabilities and equity
SHPH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
SHPH balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & short-term investments | $334,005 | $1.9M | $5.5M | $8.4M | $504,749 | $117,153 | $352,390 | $50,709 |
| Cash & equivalents | $334,005 | $1.9M | $2.6M | $8.4M | $504,749 | $117,153 | $352,390 | $50,709 |
| Short-term investments | — | $2.9M | $2.9M | $0 | — | — | — | — |
| Receivables | $0 | $14,901 | $14,901 | $0 | $0 | $211,455 | $3,825 | $49,210 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $168,906 | $275,872 | $114,473 | $161,148 | $4,866 | $12,579 | $257,742 | $2,541 |
| Total current assets | $502,911 | $2.2M | $5.6M | $8.6M | $509,615 | $341,187 | $613,957 | $102,460 |
| Property, plant & equipment (net) | $119,702 | $295,373 | $358,731 | $68,714 | $135,546 | $196,380 | $838 | $18,838 |
| Goodwill & intangible assets | $9.8M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $12,122 | $0 | $0 | $6,480 | $6,480 | $6,480 | $6,480 | $0 |
| Total assets | $10.5M | $2.5M | $6.0M | $8.7M | $651,641 | $544,047 | $621,275 | $121,298 |
| Liabilities | ||||||||
| Accounts payable | $1.5M | $596,600 | $283,306 | $129,245 | $828,313 | $516,966 | $30,731 | $79,104 |
| Short-term debt | $77,194 | $935,384 | $648,478 | $748,296 | $916,435 | $744,909 | $400,000 | $314,377 |
| Deferred revenue | — | — | — | — | $378,558 | $228,389 | $17,544 | — |
| Total current liabilities | $8.0M | $1.5M | $1.0M | $975,676 | $2.2M | $2.1M | $593,819 | $405,646 |
| Long-term debt | $0 | $0 | $135,089 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $232,147 | $298,997 | $356,606 | $62,823 | $129,376 | $187,844 | — | — |
| Other long-term liabilities | $254,640 | $263,369 | $718,639 | $0 | $62,441 | $129,376 | $0 | $0 |
| Total liabilities | $8.2M | $1.8M | $1.9M | $975,676 | $2.3M | $2.2M | $593,819 | $405,646 |
| Shareholders' equity | ||||||||
| Common stock & paid-in capital | $20 | $41 | $20 | $136 | $93 | $93 | $179 | $450,000 |
| Retained earnings (deficit) | −$46.3M | −$34.6M | −$25.4M | −$8.9M | −$5.8M | −$4.5M | −$1.9M | −$1.3M |
| Accumulated other comprehensive income | — | — | — | — | $16,340 | $16,340 | $16,340 | — |
| Total shareholders' equity | $2.3M | $709,152 | $4.1M | $7.7M | −$1.6M | −$1.7M | $27,456 | −$284,348 |
| Key figures | ||||||||
| Total debt | $232,147 | $1.2M | $1.1M | $748,296 | $978,877 | $874,285 | $400,000 | $314,377 |
| Net cash (debt) | $101,858 | $746,672 | $4.4M | $7.7M | −$474,128 | −$757,132 | −$47,610 | −$263,668 |
| Working capital | −$7.5M | $677,148 | $4.6M | $7.6M | −$1.7M | −$1.8M | $20,138 | −$303,186 |
| Tangible book value | −$7.6M | $709,152 | $4.1M | $7.7M | −$1.6M | −$1.7M | $27,456 | −$284,348 |
| Book value per share | — | $0.69 | $2.55 | $7.42 | −$1.20 | −$1.24 | $0.02 | −$0.21 |
| Shares outstanding | — | 1.0M | 1.6M | 1.0M | 1.4M | 1.4M | 1.4M | 1.4M |
| Current ratio | 0.06 | 1.44 | 5.37 | 8.79 | 0.23 | 0.16 | 1.03 | 0.25 |
| Quick ratio | 0.04 | 1.26 | 5.26 | 8.63 | 0.23 | 0.16 | 0.60 | 0.25 |
| Debt / equity | 0.10 | 1.65 | 0.27 | 0.10 | — | — | 14.57 | — |
| Equity / assets | 21.5% | 28.3% | 68.1% | 88.7% | −249.9% | −310.7% | 4.4% | −234.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $90,238 | $1.1M | $334,005 | $2.1M | $4.8M | $4.5M | $1.9M | $156,656 | $2.3M | $4.2M | $5.5M | $6.8M |
| Cash & equivalents | $90,238 | $1.1M | $334,005 | $2.1M | $4.8M | $4.5M | $1.9M | $156,656 | $695,594 | $1.4M | $2.6M | $3.9M |
| Short-term investments | — | — | — | — | — | — | $0 | $0 | $1.6M | $2.8M | $2.9M | $2.9M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4 | $7,226 | $11,964 | $14,901 | $12,435 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1 | $1 | $0 | $170,104 |
| Other current assets | $306,115 | $1.4M | $168,906 | $1.2M | $374,245 | $446,790 | $290,773 | $204,691 | $139,517 | $211,175 | $114,473 | $6,480 |
| Total current assets | $396,353 | $2.5M | $502,911 | $3.3M | $5.2M | $5.0M | $2.2M | $361,351 | $2.5M | $4.4M | $5.6M | $7.0M |
| Property, plant & equipment (net) | $82,632 | $101,464 | $119,702 | $246,709 | $264,025 | $278,913 | $295,373 | $312,217 | $327,665 | $342,902 | $358,731 | $380,210 |
| Goodwill & intangible assets | $8.6M | $9.2M | $9.8M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $13.7M | $0 | $12,122 | $30,305 | $48,487 | $71,880 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $22.8M | $11.8M | $10.5M | $3.5M | $5.5M | $5.3M | $2.5M | $673,568 | $2.8M | $4.8M | $6.0M | $7.4M |
| Liabilities | ||||||||||||
| Accounts payable | $2.8M | $1.8M | $1.5M | $1.5M | $1.2M | $896,885 | $596,600 | $1.3M | $364,891 | $347,556 | $283,306 | $180,000 |
| Short-term debt | $82,811 | $79,962 | $77,194 | $492,013 | $517,822 | $884,084 | $935,384 | $308,652 | $888,327 | $995,950 | $648,478 | $523,859 |
| Deferred revenue | — | — | — | — | — | — | — | — | −$62,092 | — | — | −$180,000 |
| Total current liabilities | $3.5M | $8.3M | $8.0M | $2.0M | $1.7M | $1.8M | $1.5M | $1.7M | $1.4M | $1.5M | $1.0M | $810,437 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $135,089 | $134,382 |
| Lease obligations | — | $214,013 | $232,147 | $249,815 | $267,028 | $283,336 | $298,997 | $314,257 | $329,117 | $343,154 | $356,606 | $369,459 |
| Other long-term liabilities | $148,098 | $157,474 | $254,640 | $183,856 | $206,124 | $242,748 | $263,369 | $329,712 | $626,944 | $503,217 | $718,639 | $821,250 |
| Total liabilities | $3.6M | $8.5M | $8.2M | $2.1M | $1.9M | $2.0M | $1.8M | $2.0M | $2.0M | $2.0M | $1.9M | $1.8M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $9 | $57 | $20 | $13 | $11 | $63 | $41 | $29 | $21 | $168 | $20 | $160 |
| Retained earnings (deficit) | −$51.6M | −$48.5M | −$46.3M | −$43.7M | −$41.3M | −$37.6M | −$34.6M | −$33.0M | −$29.2M | −$17.2M | −$25.4M | −$13.8M |
| Total shareholders' equity | $19.2M | $3.3M | $2.3M | $1.4M | $3.6M | $3.3M | $709,152 | −$1.3M | $801,434 | $2.8M | $4.1M | $5.6M |
| Key figures | ||||||||||||
| Total debt | $195,158 | $214,013 | $232,147 | $667,331 | $712,981 | $1.1M | $1.2M | $564,257 | $1.2M | $1.3M | $1.1M | $966,666 |
| Net cash (debt) | −$104,920 | $875,933 | $101,858 | $1.4M | $4.1M | $3.4M | $746,672 | −$407,601 | $1.2M | $2.9M | $4.4M | $5.8M |
| Working capital | −$3.1M | −$5.8M | −$7.5M | $1.3M | $3.5M | $3.2M | $677,148 | −$1.3M | $1.1M | $2.9M | $4.6M | $6.2M |
| Tangible book value | $10.5M | −$5.9M | −$7.6M | $1.4M | $3.6M | $3.3M | $709,152 | −$1.3M | $801,434 | $2.8M | $4.1M | $5.6M |
| Book value per share | $18.90 | — | — | — | — | — | — | −$1.27 | $0.78 | $1.67 | $2.52 | $3.56 |
| Shares outstanding | 1.0M | — | — | — | — | — | — | 1.0M | 1.0M | 1.7M | 1.6M | 1.6M |
| Current ratio | 0.11 | 0.30 | 0.06 | 1.66 | 3.07 | 2.78 | 1.44 | 0.22 | 1.79 | 2.96 | 5.37 | 8.63 |
| Quick ratio | 0.03 | 0.13 | 0.04 | 1.07 | 2.85 | 2.53 | 1.25 | 0.09 | 1.69 | 2.82 | 5.26 | 8.41 |
| Debt / equity | 0.01 | 0.06 | 0.10 | 0.48 | 0.20 | 0.34 | 1.65 | — | 1.44 | 0.47 | 0.27 | 0.17 |
| Equity / assets | 84.1% | 28.3% | 21.5% | 39.4% | 65.5% | 61.9% | 28.3% | −195.3% | 28.5% | 58.1% | 68.1% | 76.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.
SHPH financial position
At the end of fiscal 2025 (December 31, 2025), Shuttle Pharmaceuticals had total assets of $10.5 million (up 318.0% from a year earlier), total liabilities of $8.2 million and shareholders' equity of $2.3 million. It held $0.3 million in cash and short-term investments against $0.2 million of debt, a net cash position of $0.1 million. Its current ratio was 0.06. In the latest quarter (ended June 30, 2026) total assets were $22.8 million and equity $19.2 million.
Related: SHPH income statement, SHPH cash flow statement, SHPH key metrics. See the SHPH stock overview for the latest quote and news.
SHPH balance sheet FAQ
What are Shuttle Pharmaceuticals's total assets?
Shuttle Pharmaceuticals reported total assets of $10.5 million at the end of fiscal 2025 (December 31, 2025), compared with $2.5 million a year earlier.
How much debt does Shuttle Pharmaceuticals have?
Shuttle Pharmaceuticals had $0.2 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.10.
How much cash does Shuttle Pharmaceuticals have?
Shuttle Pharmaceuticals held $0.3 million in cash and short-term investments at the end of fiscal 2025; with $0.2 million of debt that is net cash of $0.1 million.
What is Shuttle Pharmaceuticals's book value?
Shuttle Pharmaceuticals's shareholders' equity (book value) was $2.3 million at the end of fiscal 2025.
What is Shuttle Pharmaceuticals's current ratio?
Shuttle Pharmaceuticals had current assets of $0.5 million and current liabilities of $8.0 million, a current ratio of 0.06 (current liabilities exceed current assets).
How much goodwill does Shuttle Pharmaceuticals have?
Shuttle Pharmaceuticals carried $9.8 million of goodwill and intangible assets, 93.9% of total assets, at the end of fiscal 2025.